IL13 and glioblastoma: As an example, treatment with doxorubicin encapsulated in interleukin-13 (IL-13)-conjugated liposomes resulted in improved survival and enhanced tumor reduction in an intracranial model of glioblastoma multiforme (GBM) as compared to unconjugated liposomes with the same doxorubicin concentration [39].